Technology

Collaborative R&D projects

The Medicines Discovery Catapult (MDC) is a new, national centre of applied research and development (R&D) expertise set up to enable innovative, “fast-to-patient” precision medicine discovery approaches in the UK.

UK biomedical catalyst award

Centauri Therapeutics Ltd, a biotechnology company focused on the treatment of infectious diseases and cancer, has been awarded up to £945,000 under Innovate UK’s Biomedical Catalyst programme.

Biomedical Systems Acquired

This enables ERT to further expand its ability to reduce customer risk and uncertainty when imagi

Indirect Carbapenemase test

Of increasing concern is the level of carbapenem resistance amongst Gram-negative bacteria caused

Microbiology lab refurbishment

The PHE Public Health Laboratory at Central Manchester University Hospitals (CMFT) has become the first microbiology laboratory in the North West to become automated using COPAN WASPLab (Walk Away Specimen Processor) technology.

New disposable tips

Tecan has introduced a selection of clear Liquid Handling disposable tips, intended for use with Air LiHa, Air FCA and Cavro ADP pipetting options.

Analysis of urine samples

The MAST Uri System is an innovative, rapid and streamlined, semi-automated laboratory solution for the microbiological analysis of urine samples, to aid the diagnosis of urinary tract infections.

New monotest system launched

Launch Diagnostics is pleased to introduce the new VIrClia monotest system, an indirect chemiluminescent immunoassay for the detection of antibodies against infectious diseases in human serum or plasma samples.

Greiner Bio-One: Combined tubes launched

Following the successful launch of the new capillary blood collection system last autumn, Greiner Bio-One now presents the new MiniCollect Complete tube as the ideal complement to its innovative system.

bio

Roche Diagnostics: R&D Insights meeting

Roche Diagnostics UK welcomed 30 healthcare leaders for its first Roche Diagnostics R&D Insights meeting.

 

bio

Sebia enters agreement

The test mitigates the potential interference in visualisation of M-proteins in immunofixation electrophoresis caused by DARZALEX. 

Top